FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Consumer Health 4 way Nasal Decongestant Menthol Nasal Spray Recall

4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%…

Novartis Consumer Health · Lincoln, NE

Risk level
Class III
Reported by FDA
Mar 27, 2013
Recall ID
D-210-2013
Check your lot numberHow we source this data

Summary

Novartis Consumer Health recalled 4 way Nasal Decongestant Menthol Nasal Spray starting Mar 7, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-210-2013 on Mar 27, 2013. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Product description

4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Lot numbers, UPCs & expiration codes

Lot #: a) 10120598, Exp 7/13; 10127563, Exp 11/13; b) 10107920, 10108362, 10108363, 10108364, 10109881, 10110017, 10110018, 10110019, 10110020, 10120730, 10120731, 10120732, 10120733, 10120734, 10120735, 10120736, 10127556, 10127557, 10127558, and 10127559, Exp 3/13 to 10/13.

Where it was sold

Nationwide and Panama

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-210-2013
Classification
Class III
Status
Terminated
Recall initiated
Mar 7, 2013
FDA report date
Mar 27, 2013
Quantity
44,604/ .5-fl. oz. bottles and 439,452 /1-fl. oz. bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Consumer Health

Original FDA data

Every field from FDA enforcement report D-210-2013, exactly as published.

Show all FDA fields
City
Lincoln
State
NE
Status
Terminated
Country
United States
Event ID
64533
Address
10401 Hwy 6
Code information
Lot #: a) 10120598, Exp 7/13; 10127563, Exp 11/13; b) 10107920, 10108362, 10108363, 10108364, 10109881, 10110017, 10110018, 10110019, 10110020, 10120730, 10120731, 10120732, 10120733, 10120734, 10120735, 10120736, 10127556, 10127557, 10127558, and 10127559, Exp 3/13 to 10/13.
Postal code
68517-9626
Report date
Mar 27, 2013
Product type
Drugs
Recall number
D-210-2013
Classification
Class III
Recalling firm
Novartis Consumer Health
Product quantity
44,604/ .5-fl. oz. bottles and 439,452 /1-fl. oz. bottles
Termination date
Nov 26, 2014
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
Voluntary / mandated
Voluntary: Firm initiated
Product description
4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Distribution pattern
Nationwide and Panama
Recall initiation date
Mar 7, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 21, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-210-2013, published Mar 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls